Utility of non-endoscopic investigations in the practical management of oesophageal disorders

Best Practice and Research: Clinical Gastroenterology

Volumn 23, Issue 3, 2009, Pages 369-386

  Sifrim, Daniel ^a,b   Blondeau, Kathleen ^a   Mantillla, Lidia ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

dysphagia; gastro oesophageal reflux; heartburn; high resolution manometry; non cardiac chest pain; oesophageal impedance oesophageal motility; oesophageal ultrasound; pH metry

Indexed keywords

ARTICLE; BARIUM MEAL; CATHETER; DIAGNOSTIC VALUE; DUODENOGASTRIC REFLUX; DYSPHAGIA; ECHOGRAPHY; ESOPHAGEAL PH MONITORING; ESOPHAGUS DISEASE; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; ESOPHAGUS MUSCLE; GASTROESOPHAGEAL REFLUX; HUMAN; IMPEDANCE; MOTOR DYSFUNCTION; PH MEASUREMENT; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; SPECTROPHOTOMETRY; SYMPTOM; THORAX PAIN;

ESOPHAGEAL ACHALASIA; ESOPHAGEAL DISEASES; ESOPHAGEAL STENOSIS; GASTROESOPHAGEAL REFLUX; HUMANS; MANOMETRY; MONITORING, AMBULATORY; PERISTALSIS; RISK FACTORS; SCLERODERMA, SYSTEMIC;

EID: 66349091157     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2009.03.005     Document Type: Article

References (109)

1. Vakil N., van Zanten S.V., Kahrilas P., et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101 (2006) 1900-1920
2. Dent J., El-Serag H.B., Wallander M.A., et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54 (2005) 710-717
3. Wiklund I. Quality of life in patients with gastroesophageal reflux disease. Am J Gastroenterol 96 (2001) S46-S53
4. Stanghellini V., Armstrong D., Monnikes H., et al. Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire?. Aliment Pharmacol Ther 19 (2004) 463-479
5. Fass R. Symptom assessment tools for gastroesophageal reflux disease (GERD) treatment. J Clin Gastroenterol 41 (2007) 437-444
6. Bardhan K.D., and Berghofer P. Look-but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment. Digestion 75 Suppl. 1 (2007) 87-100
7. Bardhan K.D., Stanghellini V., Armstrong D., et al. International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease. Digestion 75 Suppl. 1 (2007) 48-54
8. Monnikes H., Pfaffenberger B., Gatz G., et al. Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole. Digestion 75 Suppl. 1 (2007) 62-68
9. Stanghellini V. ReQuest - the challenge of quantifying both esophageal and extra-esophageal manifestations of GERD. Best Pract Res Clin Gastroenterol 18 Suppl (2004) 27-30
10. Johnson L.F., and DeMeester T.R. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 62 (1974) 325-332
11. Martinez S.D., Malagon I.B., Garewal H.S., et al. Non-erosive reflux disease (NERD)-acid reflux and symptom patterns. Aliment Pharmacol Ther 17 (2003) 537-545
12. Shapiro M., Green C., Faybush E.M., et al. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups. Aliment Pharmacol Ther 23 (2006) 321-329
13. Winter J.W., and Heading R.C. The nonerosive reflux disease-gastroesophageal reflux disease controversy. Curr Opin Gastroenterol 24 (2008) 509-515
14. Dinelli M., Passaretti S., Di F., et al. Area under pH 4: a more sensitive parameter for the quantitative analysis of esophageal acid exposure in adults. Am J Gastroenterol 94 (1999) 3139-3144
15. Rebecchi F., Di F.I., Giaccone C., et al. Improving the analysis of esophageal acid exposure by a new parameter: area under H+. Am J Gastroenterol 97 (2002) 568-574
16. Hirano I., and Richter J.E. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 102 (2007) 668-685
17. Katz P.O., Anderson C., Khoury R., et al. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors. Aliment Pharmacol Ther 12 (1998) 1231-1234
18. Fass R. Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure. Drugs 67 (2007) 1521-1530
19. Fackler W.K., Ours T.M., Vaezi M.F., et al. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology 122 (2002) 625-632
20. Fiorucci S., Santucci L., Chiucchiu S., et al. Gastric acidity and gastroesophageal reflux patterns in patients with esophagitis. Gastroenterology 103 (1992) 855-861
21. Orr W.C., and Harnish M.J. The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity. Aliment Pharmacol Ther 17 (2003) 1553-1558
22. Katz P., Gideon R.M., and Tutuian R. Reflux symptoms on twice daily (BID) proton pump inhibitor (PPI) associated with non acid reflux; a manifestation of hypersensitive esophagus?. [abstract]. Gastroenterology 128 (2005) A130
23. Richter J.E. The patient with refractory gastroesophageal reflux disease. Dis Esophagus 19 (2006) 443-447
24. Ahmed T.F., Khandwala F., Abelson T.I., et al. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians. Am J Gastroenterol 101 (2006) 470-478
25. Farrokhi F., and Vaezi M.F. Extra-esophageal manifestations of gastroesophageal reflux. Oral Dis 13 (2007) 349-359
26. Vaezi M.F. Sore throat and a red hypopharynx: is it reflux?. Clin Gastroenterol Hepatol 5 (2007) 1379-1382
27. Wiener G.J., Tsukashima R., Kelly C., et al. Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice (2008)
28. McCollough M., Jabbar A., Cacchione R., et al. Proximal sensor data from routine dual-sensor esophageal pH monitoring is often inaccurate. Dig Dis Sci 49 (2004) 1607-1611
29. Weusten B.L., Akkermans L.M., vanBerge-Henegouwen G.P., et al. Spatiotemporal characteristics of physiological gastroesophageal reflux. Am J Physiol 266 (1994) G357-G362
30. Fass R., Hell R., Sampliner R.E., et al. Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci 44 (1999) 2263-2269
31. Pandolfino J.E., Richter J.E., Ours T., et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 98 (2003) 740-749
32. Pandolfino J.E., Lee T.J., Schreiner M.A., et al. Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo pH monitoring system. Dis Esophagus 19 (2006) 177-182
33. Wong W.M., Bautista J., Dekel R., et al. Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring - a randomized trial. Aliment Pharmacol Ther 21 (2005) 155-163
34. Prakash C., and Clouse R.E. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease. Clin Gastroenterol Hepatol 3 (2005) 329-334
35. Arora A.S., and Murray J.A. Streamlining 24-hour pH study for GERD: use of a 3-hour postprandial test. Dig Dis Sci 48 (2003) 10-15
36. Galmiche J.P., Clouse R.E., Balint A., et al. Functional esophageal disorders. Gastroenterology 130 (2006) 1459-1465
37. Wiener G.J., Richter J.E., Copper J.B., et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 83 (1988) 358-361
38. Singh S., Richter J.E., Bradley L.A., et al. The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci 38 (1993) 1402-1408
39. Breumelhof R., and Smout A.J. The symptom sensitivity index: a valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol 86 (1991) 160-164
40. Weusten B.L., Roelofs J.M., Akkermans L.M., et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 107 (1994) 1741-1745
41. Taghavi S.A., Ghasedi M., Saberi-Firoozi M., et al. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut 54 (2005) 1067-1071
42. Lopez-Alonso M., Moya M.J., Cabo J.A., et al. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux. Pediatrics 118 (2006) e299-e308
43. Shay S., Tutuian R., Sifrim D., et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 99 (2004) 1037-1043
44. Zerbib F., des Varannes S.B., Roman S., et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 22 (2005) 1011-1021
45. Mainie I., Tutuian R., Shay S., et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 55 (2006) 1398-1402
46. Zerbib F., Roman S., Ropert A., et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 101 (2006) 1956-1963
47. Blondeau K., Dupont L.J., Mertens V., et al. Improved diagnosis of gastro-oesophageal reflux in patients with unexplained chronic cough. Aliment Pharmacol Ther 25 (2007) 723-732
48. Sharma N., Agrawal A., Freeman J., et al. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol 6 (2008) 521-524
49. Sifrim D., Dupont L., Blondeau K., et al. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut 54 (2005) 449-454
50. Tutuian R., Mainie I., Agrawal A., et al. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest 130 (2006) 386-391
51. Conchillo J.M., Schwartz M.P., Selimah M., et al. Acid and non-acid reflux patterns in patients with erosive esophagitis and non-erosive reflux disease (NERD): a study using intraluminal impedance monitoring. Dig Dis Sci (2007)
52. Emerenziani S., Sifrim D., Habib F.I., et al. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Gut 57 (2008) 443-447
53. Savarino E., Zentilin P., Tutuian R., et al. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol 103 (2008) 2685-2693
54. Blondeau K., Mertens V., Vanaudenaerde B.A., et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J 31 (2008) 707-713
55. Anandasabapathy S., and Jaffin B.W. Multichannel intraluminal impedance in the evaluation of patients with persistent globus on proton pump inhibitor therapy. Ann Otol Rhinol Laryngol 115 (2006) 563-570
56. Tack J., Koek G., Demedts I., et al. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?. Am J Gastroenterol 99 (2004) 981-988
57. Stein H.J., Kauer W.K., Feussner H., et al. Bile acids as components of the duodenogastric refluxate: detection, relationship to bilirubin, mechanism of injury, and clinical relevance. Hepatogastroenterology 46 (1999) 66-73
58. Vaezi M.F., Singh S., and Richter J.E. Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 108 (1995) 1897-1907
59. Vaezi M.F., and Richter J.E. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 111 (1996) 1192-1199
60. Hak N.G., Mostafa M., Salah T., et al. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus. Hepatogastroenterology 55 (2008) 442-447
61. Pace F., Sangaletti O., Pallotta S., et al. Biliary reflux and non-acid reflux are two distinct phenomena: a comparison between 24-hour multichannel intraesophageal impedance and bilirubin monitoring. Scand J Gastroenterol 42 (2007) 1031-1039
62. Vaezi M.F., and Richter J.E. Contribution of acid and duodenogastro-oesophageal reflux to oesophageal mucosal injury and symptoms in partial gastrectomy patients. [see comment]. Gut 41 (1997) 297-302
63. Todd J.A., Basu K.K., and de Caestecker J.S. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus. Aliment Pharmacol Ther 21 (2005) 969-975
64. Champion G., Richter J.E., Vaezi M.F., et al. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 107 (1994) 747-754
65. Koek G.H., Sifrim D., Lerut T., et al. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 52 (2003) 1397-1402
66. Spechler S.J., and Castell D.O. Classification of oesophageal motility abnormalities. Gut 49 (2001) 145-151
67. Kahrilas P.J., Ghosh S.K., and Pandolfino J.E. Esophageal motility disorders in terms of pressure topography: the Chicago Classification. J Clin Gastroenterol 42 (2008) 627-635
68. Kahrilas P., and Pandolfino J.E. Motility disorders of the esophagus. In: Yamada T. (Ed). Textbook of gastroenterology (2003), Lippincott Williams & Wilkins, Philadelphia 1165-1195
69. Fox M., Hebbard G., Janiak P., et al. High-resolution manometry predicts the success of oesophageal bolus transport and identifies clinically important abnormalities not detected by conventional manometry. Neurogastroenterol Motil 16 (2004) 533-542
70. Mittal R.K., Liu J., Puckett J.L., et al. Sensory and motor function of the esophagus: lessons from ultrasound imaging. Gastroenterology 128 (2005) 487-497
71. Tutuian R., and Castell D.O. Clarification of the esophageal function defect in patients with manometric ineffective esophageal motility: studies using combined impedance-manometry. Clin Gastroenterol Hepatol 2 (2004) 230-236
72. Tutuian R., and Castell D.O. Combined multichannel intraluminal impedance and manometry clarifies esophageal function abnormalities: study in 350 patients. Am J Gastroenterol 99 (2004) 1011-1019
73. Nguyen H.N., Silny J., and Matern S. Multiple intraluminal electrical impedancometry for recording of upper gastrointestinal motility: current results and further implications. Am J Gastroenterol 94 (1999) 306-317
74. Pandolfino J.E., Kwiatek M.A., Nealis T., et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 135 (2008) 1526-1533
75. Vaezi M.F., Baker M.E., Achkar E., et al. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut 50 (2002) 765-770
76. Mittal R.K., Kassab G., Puckett J.L., et al. Hypertrophy of the muscularis propria of the lower esophageal sphincter and the body of the esophagus in patients with primary motility disorders of the esophagus. Am J Gastroenterol 98 (2003) 1705-1712
77. Conchillo J.M., Selimah M., Bredenoord A.J., et al. Assessment of oesophageal emptying in achalasia patients by intraluminal impedance monitoring. Neurogastroenterol Motil 18 (2006) 971-977
78. Richter J.E., and Castell D.O. Diffuse esophageal spasm: a reappraisal. Ann Intern Med 100 (1984) 242-245
79. Katz P.O., Dalton C.B., Richter J.E., et al. Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years' experience with 1161 patients. Ann Intern Med 106 (1987) 593-597
80. Reidel W.L., and Clouse R.E. Variations in clinical presentation of patients with esophageal contraction abnormalities. Dig Dis Sci 30 (1985) 1065-1071
81. Crozier R.E., Glick M.E., Gibb S.P., et al. Acid-provoked esophageal spasm as a cause of noncardiac chest pain. Am J Gastroenterol 86 (1991) 1576-1580
82. Clouse R.E., and Lustman P.J. Psychiatric illness and contraction abnormalities of the esophagus. N Engl J Med 309 (1983) 1337-1342
83. Alvarez W.C. The corkscrew esophagus. Gastroenterology 25 (1953) 450
84. Clouse R.E., Eckert T.C., and Staiano A. Hiatus hernia and esophageal contraction abnormalities. Am J Med 81 (1986) 447-450
85. Kahrilas P.J., Clouse R.E., and Hogan W.J. American gastroenterological association technical review on the clinical use of esophageal manometry. Gastroenterology 107 (1994) 1865-1884
86. Dalton C.B., Castell D.O., Hewson E.G., et al. Diffuse esophageal spasm. A rare motility disorder not characterized by high-amplitude contractions. Dig Dis Sci 36 (1991) 1025-1028
87. Achem S.R., and Benjamin S.B. Esophageal dysmotility (spastic dysmotility). In: Castell D.O. (Ed). The esophagus (1995), Little, Brown, Boston 247-268
88. Barham C.P., Gotley D.C., Fowler A., et al. Diffuse oesophageal spasm: diagnosis by ambulatory 24 hour manometry. Gut 41 (1997) 151-155
89. Clouse R.E., and Prakash C. Topographic esophageal manometry: an emerging clinical and investigative approach. Dig Dis 18 (2000) 64-74
90. Rice J., Pandolfino J., Ghosh S.K., et al. High-resolution manometry (HRM) in the assessment of distal esophageal peristaltic abnormalities: computerized algorithms of analysis tested on 281 non-achalasic patients. Gastroenterology 132 (2007) A598-A598
91. Tutuian R., Mainie I., Agrawal A., et al. Symptom and function heterogenicity among patients with distal esophageal spasm: studies using combined impedance-manometry. Am J Gastroenterol 101 (2006) 464-469
92. Conchillo J.M., Nguyen N.Q., Samsom M., et al. Multichannel intraluminal impedance monitoring in the evaluation of patients with non-obstructive Dysphagia. Am J Gastroenterol 100 (2005) 2624-2632
93. Pehlivanov N., Liu J., Kassab G.S., et al. Relationship between esophageal muscle thickness and intraluminal pressure in patients with esophageal spasm. Am J Physiol Gastrointest Liver Physiol 282 (2002) G1016-G1023
94. Dogan I., Puckett J.L., Padda B.S., et al. Prevalence of increased esophageal muscle thickness in patients with esophageal symptoms. Am J Gastroenterol 102 (2007) 137-145
95. Bassotti G., Battaglia E., Debernardi V., et al. Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum 40 (1997) 2252-2259
96. Klein H.A., Wald A., Graham T.O., et al. Comparative studies of esophageal function in systemic sclerosis. Gastroenterology 102 (1992) 1551-1556
97. Akesson A., and Wollheim F.A. Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol 28 (1989) 281-286
98. Basilisco G., Barbera R., Molgora M., et al. Acid clearance and oesophageal sensitivity in patients with progressive systemic sclerosis. Gut 34 (1993) 1487-1491
99. Drane W.E., Karvelis K., Johnson D.A., et al. Progressive systemic sclerosis: radionuclide esophageal scintigraphy and manometry. Radiology 160 (1986) 73-76
100. Ebert E.C. Esophageal disease in scleroderma. J Clin Gastroenterol 40 (2006) 769-775
101. Martin J., Ferraro P., and Duranceau A. Reflux esophagitis and scleroderma. Chest Surg Clin N Am 11 (2001) 619-638 viii
102. Savarino E., Bazzica M., Zentilin P., et al. Gastro-esophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med (2008)
103. Villadsen G.E., Storkholm J.H., Hendel L., et al. Impedance planimetric characterization of esophagus in systemic sclerosis patients with severe involvement of esophagus. Dig Dis Sci 42 (1997) 2317-2326
104. Miller L.S., Liu J.B., Klenn P.J., et al. Endoluminal ultrasonography of the distal esophagus in systemic sclerosis. Gastroenterology 105 (1993) 31-39
105. Kahrilas P.J., Dodds W.J., and Hogan W.J. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology 94 (1988) 73-80
106. Richter J.E., Blackwell J.N., Wu W.C., et al. Relationship of radionuclide liquid bolus transport and esophageal manometry. J Lab Clin Med 109 (1987) 217-224
107. Leite L.P., Johnston B.T., Barrett J., et al. Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Sci 42 (1997) 1859-1865
108. Nguyen N.Q., Tippett M., Smout A.J., et al. Relationship between pressure wave amplitude and esophageal bolus clearance assessed by combined manometry and multichannel intraluminal impedance measurement. Am J Gastroenterol (2006)
109. Kim J.H., Rhee P.L., Son H.J., et al. Is all ineffective esophageal motility the same? A clinical and high-frequency intraluminal US study. Gastrointest Endosc 68 (2008) 422-431